34D.F DiaSorin SpA

Healthcare Biotechnology Frankfurt Exchange
82.88 EUR
Close of Nov 12, 2026
54.23 83.34
Market cap
EUR 4.08B
P/E
31.0x
P/B
2.84x
ROE
9.8%
Dividend yield
1.56%
Fundamental score
-

Ratios use the latest price and the fiscal year ending Dec 2025.

Is 34D.F undervalued?

Graham number
Price82.88
Graham value41.90
Premium97.8%

34D.F trades 97.8% above its Graham number.

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

DiaSorin SpA fundamental analysis

No fundamental analysis for DiaSorin SpA yet.

DiaSorin SpA stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About DiaSorin SpA

DiaSorin S.p.A. engages in research and development, manufacture, and distribution of immunodiagnostics and molecular diagnostics testing kits in Europe, North America, and internationally. It provides various immunodiagnostic in the areas, including infectious diseases, gastrointestinal diseases, hepatitis and retroviruses, endocrinology, metabolic disorders, tumor markers, and oncology under LIAISON XL and LIAISON XS name. The company also offers Simplexa, a congenital CMV…

Full company profile